Tenax Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
TENX
CUSIP
88032L605
Type
Equity
Class
COM NEW
Num filings
22
Total reported value, excl. options
$8.43 M
Manager Report Date Value ($000) Shares Option Type